Summit Securities Group’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$113K	Buy	+33,276	New	+$113K	0.02%	241
2024 Q3	–	Sell	-878	Closed	-$5K	–	516
2024 Q2	$5K	Buy	+878	New	+$5K	﹤0.01%	365